1. AB0186 NO PREDICTIVE VALUE OF ADALIMUMAB SERUM LEVELS AND ANTI-ADALIMUMAB ANTIBODIES AT TIME OF ADALIMUMAB FAILURE FOR PREDICTION OF RESPONSE TO THE NEXT BDMARD. (2nd June 2020) Authors: Den Broeder, N.; Ulijn, E.; Wientjes, M.; Van Herwaarden, N.; Meek, I.; Tweehuysen, L.; Van der Maas, A.; Van den Bemt, B.; Den Broeder, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0342 Study on Abatacept and Tocilizumab Attenuation (SONATA) in Rheumatoid Arthritis Patients: A Retrospective, Explorative Cohort Study. (15th July 2016) Authors: Bouman, C.; Tweehuysen, L.; Haverkort, D.; van den Ende, C.; Fransen, J.; van der Maas, A.; den Broeder, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0127 Open-label non-mandatory transitioning from originator etanercept to biosimilar sb4: 6-month results from a controlled cohort study. (12th June 2018) Authors: Tweehuysen, L.; Huiskes, V.J.B.; van den Bemt, B.J.F.; Vriezekolk, J.E.; Teerenstra, S.; van den Hoogen, F.H.J.; van den Ende, C.H.; den Broeder, A.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0025 Shift in Genetic Composition of an IL-32 Promoter Polymorphism Resuls in a Higher Cytokine Production in RA Patients. (9th June 2015) Authors: Damen, M.; Heinhuis, B.; Tweehuysen, L.; den Broeder, A.; Netea, M.; Popa, C.; Joosten, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0058 Prediction of Successful Dose Reduction or Discontinuation of Biologics in Patients with Rheumatoid Arthritis: A Systematic Review. (15th July 2016) Authors: Tweehuysen, L.; van den Ende, C.; Beeren, F.; Been, E.; van den Hoogen, F.; den Broeder, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0142 High Similarity between ex-vivo Inhibited Cytokine Profiling by Golimumab and Adalimumab as A Putative Explanation for Inferior Treatment Response To Golimumab after Adalimumab Failure in Rheumatoid Arthritis. (15th July 2016) Authors: Tweehuysen, L.; Schraa, K.; Netea, M.; van den Hoogen, F.; Joosten, L.; den Broeder, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗